The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis

BACKGROUND: Procalcitonin is a biomarker that supports clinical decision-making on when to initiate and discontinue antibiotic therapy. Several cost (-effectiveness) analyses have been conducted on Procalcitonin-guided antibiotic stewardship, but none mainly based on US originated data. OBJECTIVE: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mewes, Janne C., Pulia, Michael S., Mansour, Michael K., Broyles, Michael R., Nguyen, H. Bryant, Steuten, Lotte M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478294/
https://www.ncbi.nlm.nih.gov/pubmed/31013271
http://dx.doi.org/10.1371/journal.pone.0214222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478294/
https://www.ncbi.nlm.nih.gov/pubmed/31013271
http://dx.doi.org/10.1371/journal.pone.0214222

Ejemplares similares